Showing results (91-100 of 107) with videos related to
Sort By:
Pageof 11
Asian Pacific Journal of Cancer Prevention : APJCP|December 19, 2014
Prognostic factors and adjuvant treatments for surgically treated cancers of the biliary tract: a multicentre study of the Anatolian Society of Medical Oncology (ASMO)Olcun Umit Unal, Ilhan Oztop, Tugba Kos, et al.Journal of Cancer Research and Clinical Oncology|June 23, 2012
Bevacizumab every 4 weeks is as effective as every 2 weeks in combination with biweekly FOLFIRI in metastatic colorectal cancerRamazan Yildiz, Mustafa Benekli, Metin Ozkan, et al.Oncology Research and Treatment|April 1, 2016
Pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung CancerNur Sener Dinc, Kubra Aydın, Hatice Odabas, et al.Tumori|September 18, 2010
Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancerAli Osman Kaya, Suleyman Buyukberber, Faysal Dane, et al.Journal of Pediatric Hematology/Oncology|January 23, 2013
Childhood, adolescents, and young adults (≤25 y) colorectal cancer: study of Anatolian Society of Medical OncologyMuhammet A Kaplan, Abdurrahman Isikdogan, Mahmut Gumus, et al.Oncology Letters|October 19, 2013
Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experienceUmut Kefeli, Mustafa Benekli, Alper Sevinc, et al.Journal of Cancer Research and Clinical Oncology|August 11, 2012
Nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancerOnder Tonyali, Ugur Coskun, Nur Sener, et al.Onkologie|October 11, 2013
Prognostic factors for recurrence-free survival in patients with HER2-positive early-stage breast cancer treated with adjuvant trastuzumabOnder Tonyali, Ugur Coskun, Nur Sener, et al.Breast (Edinburgh, Scotland)|July 3, 2014
Bone health in breast cancer patients: a comprehensive statement by CECOG/SAKK IntergroupTamara Rordorf, Azza Adel Hassan, Hamdy Azim, et al.Hepato-Gastroenterology|November 21, 2012
Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experienceUmut Kefeli, Suleyman Buyuberber, Murat Akyol, et al.Pageof 11